Seeing Is Believing
Currently out of the existing stock ratings of John Franzreb, 28 are a HOLD (40.58%), 41 are a BUY (59.42%).
Analyst John Franzreb, currently employed at SIDOTI, carries an average stock price target met ratio of 75.09% that have a potential upside of 33.94% achieved within 401 days.
John Franzreb’s has documented 127 price targets and ratings displayed on 13 stocks. The coverage is on Industrials, Technology, Consumer Cyclical sectors.
Most recent stock forecast was given on CTS, CTS at 07-Feb-2024.
Analyst best performing recommendations are on LDL (LYDALL).
The best stock recommendation documented was for CTS (CTS) at 2/7/2024. The price target of $46 was fulfilled within 5 days with a profit of $3.29 (7.7%) receiving and performance score of 15.41.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
$62
$0.02 (0.03%)
$58
1 years 8 months 18 days ago
(03-Mar-2023)
5/7 (71.43%)
$0.4 (0.65%)
446
Hold
$50
$-11.98 (-19.33%)
$50
1 years 11 months ago
(21-Dec-2022)
4/5 (80%)
$-9.53 (-16.01%)
57
Buy
$62
$0.02 (0.03%)
$48
2 years 20 days ago
(01-Nov-2022)
4/7 (57.14%)
$2.54 (4.27%)
189
Buy
$67
$5.02 (8.10%)
$70
2 years 9 months 4 days ago
(17-Feb-2022)
6/12 (50%)
$21.66 (47.77%)
44
Buy
$75
$13.02 (21.01%)
$49
3 years 6 months 26 days ago
(26-Apr-2021)
2/3 (66.67%)
$11.77 (18.61%)
606
What Year was the first public recommendation made by John Franzreb?